Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis
Abstract:
Provided herein are combination therapies for the treatment of progeroid diseases and conditions, cellular aging, bone diseases, and cardiovascular diseases. The provided combination therapies target the aberrant farnesylation of the mutant lamin A protein progerin and increase progerin clearance.
Information query
Patent Agency Ranking
0/0